Golden Helix
PrivateLast Round
Grant
Oct 7, 2025
Total Funding Raised
$7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Golden Helix is a software company that develops and provides genomic data analysis software for precision medicine and clinical labs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Golden Helix Comparables
Compare Golden Helix with similar companies based on industry and business-model similarity.
Golden Helix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 7, 2025 | ||||
| Grant | Sep 26, 2023 |
Golden Helix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2025
$2.2M grant from NIH and NHGRI
- Sep 26, 2023
$400K grant from NIH and NHGRI.
Golden Helix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Golden Helix's valuation, stock price, and market status.
Is Golden Helix a public or private company?
Golden Helix is a private company.
What is the current stock price of Golden Helix?
Golden Helix is a private company with no public stock price. No recent secondary market data is available.
How much is Golden Helix worth (valuation)?
Valuation information for Golden Helix is not publicly available.
Can I buy Golden Helix stock?
Golden Helix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Golden Helix's last funding round?
Golden Helix's most recent funding round was Grant on October 7, 2025.
Who are the main investors in Golden Helix?
Key investors in Golden Helix include National Institutes of Health (NIH).
Will Golden Helix IPO soon?
No public IPO plans have been announced for Golden Helix.
How can I track Golden Helix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Golden Helix's secondary market activity and sign up for updates.